Zhejiang Yatai Pharmaceutical Co.,Ltd. Posted 81.4 Million Yuan Net Loss in First Three Quarters of 2022
Listen to the full version

Zhejiang Yatai Pharmaceutical Co.,Ltd. (浙江亚太药业股份有限公司) (002370.SZ) reported a net loss of 81.4 million yuan in the first three quarters of 2022, narrowing 14.4% year-on-year.
Meanwhile, the company posted 234.1 million yuan in revenue, up 7.3% year-on-year.
At the end of the reporting period, it had 1.5 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 76.8%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR